Improvement of risk assessment by integrating toxicological and epidemiological approaches: the case of isoflavones

Biochemistry, Genetics and Molecular Biology

• Glucuronide 100%
• Gene Expression 72%
• Aglycone 63%
• Peripheral Blood Mononuclear Cell 45%
• Isoflavone 36%
• Glucoside 36%
• Metabolic Pathway 27%
• Intervention Study 27%
• Species Difference 27%
• Target Tissue 27%
• Daidzein 27%
• Genistein 27%
• Metabolite 18%
• Glucuronidation 18%
• Postmenopause 18%
• Glucosidase 18%
• Blood Plasma 18%
• Gene Expression Profiling 9%
• Gene Expression Data 9%
• Hydrolase 9%
• Animal Model 9%
• Intestinal Mucosal Barrier 9%
• Phlorizin 9%
• Sulfation 9%
• Glucocerebrosidase 9%
• Enzyme 9%
• Catalytic Efficiency 9%
• Animal Experiment 9%
• Body Weight 9%
• Reporter Gene 9%
• Estrogen Receptor 9%
• Low Drug Dose 9%
• Sulfate 9%
• Cancer Cell 9%
• Glucosylceramidase 9%
• Lactase 9%
• Genistin 9%
• Glycoside 9%
• Daidzin 9%
• Estradiol 9%
• Biological Activity 9%

Neuroscience

• Glucuronide 100%
• Gene Expression 81%
• Aglycone 63%
• Peripheral Blood Mononuclear Cell 45%
• In Vitro 36%
• Isoflavone 36%
• Metabolic Pathway 27%
• Daidzein 27%
• Genistein 27%
• Glucuronidation 18%
• Adipose Tissue 18%
• Glucosidase 18%
• Blood Plasma 18%
• Cell Line 9%
• In Vivo 9%
• Diethylstilbestrol 9%
• Transcriptomics 9%
• Reporter Gene 9%
• Glucosylceramidase 9%
• Glycosylceramidase 9%
• Intestine Enzyme 9%
• Estrogen Receptor 9%
• Glycoside 9%
• Daidzin 9%
• Genistin 9%
• Sulfation 9%
• Steroid Hormone 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Glucuronide 100%
• Aglycone 63%
• Isoflavone 36%
• Intervention Study 27%
• Genistein 27%
• Daidzein 27%
• Systemic Circulation 18%
• Glucosidase 18%
• Estrogen Receptor 9%
• Toxicology 9%
• Genistin 9%
• Intestine Enzyme 9%
• Glucosylceramidase 9%
• Glycosylceramidase 9%
• Biological Marker 9%
• Bioavailability 9%
• Diethylstilbestrol 9%
• Glycoside 9%
• Breast Cancer 9%
• Daidzin 9%
• Sulfate 9%
• Steroid Hormone 9%